Transfer of a rational formulation and process development approach for 2D inks for pharmaceutical 2D and 3D printing
The field of pharmaceutical 3D printing is growing over the past year, with Spitam® as the first 3D printed dosage form on the market. Showing the suitability of a binder jetting process for dosage forms. Although the development of inks for pharmaceutical field is more trail and error based, focusi...
Saved in:
Main Authors: | Maximilian Schulz (Author), Malte Bogdahn (Author), Simon Geissler (Author), Julian Quodbach (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
3D printing of amorphous solid dispersions: A comparison of fused deposition modeling and drop-on-powder printing
by: Nadine Gottschalk, et al.
Published: (2023) -
Drop-on-powder 3D printing of amorphous high dose oral dosage forms: Process development, opportunities and printing limitations
by: Nadine Gottschalk, et al.
Published: (2023) -
Biocomposite Inks for 3D Printing
Published: (2021) -
The Ink-Stain (Tache d'encre) — Volume 2
by: Bazin, René, 1853-1932 -
Hot-Melt Extrusion Process Fluctuations and Their Impact on Critical Quality Attributes of Filaments and 3D-Printed Dosage Forms
by: Hanna Ponsar, et al.
Published: (2020)